Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nader Khader is active.

Publication


Featured researches published by Nader Khader.


American Journal of Cardiology | 1999

Same-day combined coronary angioplasty and minimally invasive coronary surgery

Basil S. Lewis; Eyal Porat; David A. Halon; Rony Ammar; Moshe Y. Flugelman; Nader Khader; Amnon Merdler; Giora Weisz; Gideon Uretzky

Integrated myocardial revascularization combines the advantages of angioplasty, stenting, and minimally invasive surgery to revascularize patients with multivessel coronary artery disease without cardiopulmonary bypass. This pilot study showed that a new same-day management strategy, consisting of percutaneous coronary intervention followed immediately by minimally invasive surgery, was feasible and provided complete all-arterial revascularization with minimal surgical trauma, short hospital stay, and excellent early therapeutic result in 14 patients with multivessel coronary disease.


European Journal of Heart Failure | 2001

Perceived benefit after participating in positive or negative/neutral heart failure trials: the patients' perspective.

Rita Yuval; Klari Uziel; Nomi Gordon; Amnon Merdler; Nader Khader; Basheer Karkabi; Moshe Y. Flugelman; David A. Halon; Basil S. Lewis

Clinical trials, the gold standard for the evaluation of new therapeutic strategies, may prove a drug to be beneficial, harmful or neutral according to its effect on the end‐point(s) under study.


American Journal of Cardiology | 1998

Importance of diabetes mellitus and systemic hypertension rather than completeness of revascularization in determining long-term outcome after coronary balloon angioplasty (the LDCMC registry) ☆

David A. Halon; Amnon Merdler; Moshe Y. Flugelman; Galia Shifroni; Nader Khader; Avinoam Shiran; Johnny Shahla; Basil S. Lewis

The study examined the 10-year outcome in a cohort of 227 unselected, consecutive patients (age 58+/-10 years) undergoing coronary balloon angioplasty between 1984 and 1986 and followed in a single cardiac center (Lady Davis Carmel Medical Center registry). In particular, we sought to identify the relative importance of the systemic risk factors diabetes and hypertension and the extent of coronary disease as opposed to procedure-related technical variables, the immediate success of the procedure, or completeness of revascularization. By life-table analysis (99% follow-up), 94% of the patients were alive at 5 years, and 77% at 10 years after angioplasty. Ten-year survival was reduced in patients with diabetes mellitus (59% vs 83%, p = 0.0008), in patients with previous myocardial infarction (68% vs 85%, p = 0.01), in patients with ejection fraction <50% (55% vs 82%, p = 0.005), and in patients with 3-vessel disease (58% vs 84% and 86% for 1- and 2-vessel disease, respectively, p = 0.04). Diabetes mellitus was the major independent predictor of poor survival (adjusted odds ratio 3.1, 95% confidence interval 1.55 to 6.19, p = 0.001). Survival at 10 years was identical in 199 patients in whom angioplasty was complete and in 25 in whom the balloon catheter did not cross the lesion, although bypass surgery was more frequent in the latter group (45% vs 21%, p = 0.001). Incomplete revascularization did not predict poor survival (72% vs 79% with complete angioplasty, p = NS). Event-free survival at 10 years for the whole group was 29%, and 49% of patients survived with no event other than a single repeat angioplasty procedure. Multivessel disease, hypertension, and diabetes mellitus were independent predictors of decreased event-free survival, but incomplete revascularization was not. Thus, long-term outcome after coronary balloon angioplasty was related to diabetes mellitus, systemic hypertension, and extent of coronary disease, but not to the immediate success of the procedure or completeness of revascularization.


The Cardiology | 2002

Myocardial perfusion abnormalities early (12-24 h) after coronary stenting or balloon angioplasty: implications regarding pathophysiology and late clinical outcome.

Ronen Jaffe; Simona Ben Haim; Basheer Karkabi; Avi Front; Sara Gips; Giora Weisz; Nader Khader; Amnon Merdler; Moshe Y. Flugelman; David A. Halon; Basil S. Lewis

Objective: We prospectively examined the prevalence of reversible perfusion defects on very early (12–24 h) thallium-201 single photon emission computed tomography (SPECT) scintigraphy after angiographically successful percutaneous coronary intervention (PCI) by stenting and/or stand-alone balloon angioplasty and the predictive value of these defects for late target lesion revascularization (TLR). Patients and Methods: 83 consecutive patients undergoing PCI for 88 lesions (38 balloon angioplasties, 50 stents) underwent very early (12–24 h) SPECT thallium-201 scintigraphy at rest and following administration of 0.7 mg/kg intravenous dipyridamole after PCI. Univariate and multivariate clinical, procedural and scintigraphic correlates of target lesion revascularization during long-term follow-up were examined. Results: Coronary stenting achieved a larger immediate post-PCI minimal luminal dimension (2.7 ± 0.4 vs. 2.1 ± 0.4 mm, p < 0.001) and less residual stenosis (4 ± 12 vs. 19 ± 11%, p < 0.001) than stand-alone balloon angioplasty. Nonetheless, early reversible perfusion defects were similarly present in the territory supplied by 36% of stented lesions and 32% of lesions treated by balloon angioplasty (NS). Of 81 lesions (76 patients) available for long-term clinical follow-up, TLR was performed in 11% of the stent group and 14% of the balloon angioplasty group (NS). By multivariate logistic regression analysis, diabetes mellitus was the only predictor of late TLR (p < 0.05). The type of intervention (balloon or stent) predicted neither early perfusion defects nor late TLR. Conclusions: Early 201-thallium SPECT scintigraphy was abnormal in a third of patients treated by stand-alone balloon angioplasty or by stent placement. The very early SPECT scintigraphic findings did not differentiate between balloon and stent and did not predict late TLR.


Cardiovascular Revascularization Medicine | 2012

Stenting of the unprotected left main coronary artery in patients with severe aortic stenosis prior to percutaneous valve interventions

Ronen Jaffe; Ariel Finkelstein; Basil S. Lewis; Victor Guetta; Nader Khader; Ronen Rubinshtein; David A. Halon; Amit Segev

AIMS High-risk patients with severe aortic stenosis (AS) who are candidates for transcatheter valve implantation (TAVI) or balloon aortic valvuloplasty (BAV) may additionally require revascularization of the unprotected left main coronary artery (UPLM). We aimed to assess the feasibility and procedural safety of UPLM stenting in such patients. METHODS AND RESULTS Ten cases of UPLM stenting prior to BAV or TAVI at three medical centers over a 2-year period were identified. Mean age was 84±4 years, aortic valve area was 0.70±0.12 cm(2), left ventricular ejection fraction was 58%±3%, and logistic EuroScore was 32±17. Intraaortic balloon counterpulsation was used in three patients. A single stent was used in seven patients, and two stents were used in three patients. One patient received a bare-metal stent, and the others received drug-eluting stents. No procedural complications occurred, and the patients were hemodynamically stable. Three patients subsequently underwent BAV, and seven underwent TAVI. During 6 months of follow-up, two patients died: one due to AS restenosis 6 months after BAV and one due to vascular complications 18 days after TAVI (34 days after UPLM stenting). CONCLUSIONS Stenting of the UPLM in patients with severe AS prior to percutaneous valve intervention seems feasible and safe. This approach may enable more patients to achieve comprehensive percutaneous therapy for severe coronary and valvular disease.


American Journal of Cardiology | 2001

Transesophageal Echocardiographic Findings in Patients With Nonobstructed Prosthetic Valves and Suspected Cardiac Source of Embolism

Avinoam Shiran; Neil J. Weissman; Amnon Merdler; Basheer Karkabi; Nader Khader; Sigal Aviram; Steven A. Goldstein; Ellen Pinnow; Basil S. Lewis

in DDD pacemaker patients with high degree AV block: mitral valve Doppler versus impedance cardiography. PACE 1997;20:2453–2462. 13. Bach DS, Armstrong WF, Donovan CL, Muller DW. Quantitative Doppler tissue imaging for assessment of regional myocardial velocities during transient ischemia and reperfusion. Am Heart J 1996;132:721–725. 14. Kerwin WF, Botvinick EH, O’Connell JW, Merrick SH, DeMarco T, Chatterjee K, Scheibly K, Saxon LA. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol 2000;35:1221–1227. 15. Nelson GS, Curry CW, Wyman BT, Kramer A, Declerck J, Talbot M, Douglas MR, Berger RD, McVeigh ER, Kass DA. Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation 2000;101: 2703–2709. 16. Gessner M, Blazek G, Kainz W, Gruska M, Gaul G. Application of pulsedDoppler tissue imaging in patients with dual chamber pacing:the importance of conduction time and AV delay on regional left ventricular wall dynamics. PACE 1998;21:2273–2279. 17. Garrigue S, Lafitte S, Hocini M, Jais P, Haissaguerre M, Roudaut R, Clementy J. Mechanisms of left ventricular walls resynchronization during multisite ventricular pacing: direct effects on the variations of the regional electromechanical delays and wall motion velocities. PACE 2000;23:682. 18. Yin LX, Li CM, Fu QG, Lo Y, Huang QH, Cai L, Zheng ZX. Ventricular excitation maps using tissue Doppler acceleration imaging:potential clinical application. J Am Coll Cardiol 1999;33:782–787.


The Cardiology | 1998

Behçet’ Disease (‘Silk Route Disease’) and Mitral Valve Prolapse

Norberto Calzada; Paul A. Spence; Yoshikazu Goto; Tadaaki Abe; Satoshi Sekine; Keitarou Iijima; Katsuyuki Kondoh; Tohru Sakurada; Christer Höglund; Renata Cifkova; Albert Mimran; Jozsef Tenczer; Andrew Watt; Martin R. Wilkins; Elisabeth Lindberg; Michael Stimpel; Brigitte Koch; Suzanne Oparil; Chang-Sheng Ku; Chi-Yu Yang; Wen-June Lee; Hung-Ting Chiang; Chun-Peng Liu; Shoa-Lin Lin; Magnus Edner; Kenneth Caidahl; Vernon Bonarjee; Dennis W.T. Nilsen; Steen Carstensen; Jens Berning

Dear Sir, I read with interest the article on cardiac involvement in Behçet’s disease by Morelli et al. [1]. The finding of a high incidence of mitral valve prolapse in 50% of their patients is not surprising. The association of mitral valve prolapse and Behçet’s disease was first reported from China [2]. Shen et al. [3] from Shanghai reported in 1985 also a 50% incidence of mitral valve prolapse in their patients with Behçet’s disease. Behçet’s disease occurs most frequently in Japan and the Mediterranean countries but also in the population linking these two areas to each other [4]. It occurs most frequently between latitudes 30° and 45° north, in Asian and Eurasian populations. This area coincides with the old Silk Route. Thus, Behçet’s disease is sometimes also called ‘Silk Route disease’ [2, 4]. OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO


The Cardiology | 1998

Accuracy of Exercise-Induced Left Axis QRS Deviation as a Specific Marker of Left Anterior Descending Coronary Artery Disease

Avinoam Shiran; David A. Halon; Amnon Merdler; Nabeel Makhoul; Nader Khader; Joseph Ben-David; Basil S. Lewis

In this prospective study, we examined the diagnostic accuracy of exercise-induced left QRS axis deviation as a marker of LAD coronary artery stenosis. The mean frontal QRS axis of 66 consecutive patients with chest pain and exercise-induced ST segment depression referred for diagnostic coronary angiography was analyzed and related to the angiographic findings. An exercise-induced leftward QRS axis deviation was found in 9/40 patients with and 0/26 patients without obstructive (≥70%) LAD disease (sensitivity 23%, specificity 100%, p = 0.025). In 7 of the 9 patients with left axis deviation, the lesion was proximal to and in 2 in the region of the first septal perforator. Inclusion of patients with 0° exercise-induced QRS axis deviation provided a more sensitive but less specific marker of LAD disease [sensitivity 53% (21/40), specificity 81% (21/26), p = 0.015]. The findings were similar in patients with single and with multivessel coronary artery disease. Grouping all patients in the present prospective and two previous retrospective studies (n = 165), the sensitivity was 29% and specificity 100% (p < 0.0001). Exercise-induced left QRS axis deviation was a highly specific marker of LAD coronary artery stenosis.


Jacc-cardiovascular Interventions | 2016

Aortic Root Intussusception During Transcatheter Aortic Valve Replacement

Ayman Jubran; Moshe Y. Flugelman; Nader Khader; Ronen Jaffe

Accurate valve positioning during transcatheter aortic valve replacement (TAVR) is crucial. Valve migration into the left ventricle during deployment can be treated by pulling the valve toward the aortic root or by implanting a second valve. An 83-year-old woman with severe symptomatic aortic


JAMA Internal Medicine | 2000

Patient Comprehension and Reaction to Participating in a Double-blind Randomized Clinical Trial (ISIS-4) in Acute Myocardial Infarction

Rita Yuval; David A. Halon; Amnon Merdler; Nader Khader; Basheer Karkabi; Klari Uziel; Basil S. Lewis

Collaboration


Dive into the Nader Khader's collaboration.

Top Co-Authors

Avatar

Amnon Merdler

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Basil S. Lewis

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

David A. Halon

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Moshe Y. Flugelman

Rappaport Faculty of Medicine

View shared research outputs
Top Co-Authors

Avatar

Avinoam Shiran

Rappaport Faculty of Medicine

View shared research outputs
Top Co-Authors

Avatar

Basheer Karkabi

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Ronen Jaffe

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Rita Yuval

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Ronen Rubinshtein

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Ayman Jubran

Technion – Israel Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge